Maria Sjöberg

Chief Executive Officer at Karo Pharma AB

Maria Sjöberg

Maria Sjöberg

Chief Executive Officer at Karo Pharma AB

Overview
Career Highlights

Karo Pharma AB

RelSci Relationships

188

Birthday

1964

Age

54

Relationships
RelSci Relationships are individuals Maria Sjöberg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Karo Pharma AB

Relationship likelihood: Strong

Director at Karolinska Institutet

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Karo Pharma AB

Relationship likelihood: Strong

Professor at Karolinska Institutet

Relationship likelihood: Strong

Chairman & Chief Executive Officer at CIMON AB

Relationship likelihood: Strong

Member, Nominating Committee at Karo Pharma AB

Relationship likelihood: Average

Member, Nominating Committee at Karo Pharma AB

Relationship likelihood: Average

Auditor at Öhrlings PricewaterhouseCoopers AB

Relationship likelihood: Average

Chief Executive Officer & Director at Emerentia Gruppen AB

Relationship likelihood: Average

Chairman at Ferrosan Medical Devices A/S

Relationship likelihood: Average

Paths to Maria Sjöberg
Potential Connections via
Relationship Science
You
Maria Sjöberg
Chief Executive Officer at Karo Pharma AB
Career History
Chief Executive Officer
2011 - Current

Karo Pharma AB is a development company, which engages in research & development and distribution of innovative drugs for key medical needs. It involves in development, acquisition as sale of pharmaceutical products. It also provides preclinical development services in the fields of neuropsychiatry, inflammation, autoimmune diseases and cancer. The company was founded in 1987 and is headquartered in Stockholm, Sweden.

Director-Production, Head-Research & Development
Prior - 2012

SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer.SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises).SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D.SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn.

Group Leader
Prior

Karolinska Institutet is a medical university in Solna within the Stockholm urban area, Sweden, and one of Europe's largest and most prestigious medical universities. It was founded in 1810 on Kungsholmen on the west side of Stockholm; the main campus was relocated decades later to Solna, just outside Stockholm. A second campus was established more recently in Flemingsberg, Huddinge, south of Stockholm.

Other Affiliations